This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NYC Health And Hospitals Corporation Selects Elsevier's ClinicalKey

PHILADELPHIA, September 17, 2013 /PRNewswire/ --

ClinicalKey to provide electronic clinical reference for HHC's Medical Libraries

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that New York City Health and Hospitals Corporation(HHC) has selected ClinicalKey to provide electronic medical reference and knowledge-based information to HHC's clinicians across multiple facilities.

Launched in April 2012, ClinicalKey provides the most current and clinically relevant evidence-based answers, as well as expert commentary, MEDLINE abstracts and select third-party journals. ClinicalKey offers a user-friendly interface and a journal reference package that includes many of HHC's priority journals.

As the largest municipal healthcare organization in the country, HHC serves 1.4 million New Yorkers every year. It provides medical, mental health and substance abuse services through its 11 acute care hospitals, four skilled nursing facilities, six large diagnostic and treatment centers and more than 70 community based clinics.

ClinicalKey's reference search engine is powered by Elsevier's Smart Content, tagged with EMMeT (Elsevier Merged Medical Taxonomy), which enables ClinicalKey to understand clinical terms and thus discover medical content that is the most relevant, plus find related content that would be missed by other search engines. ClinicalKey demonstrates the ability to quickly move from topic overview to in-depth specialty information in order to meet everyday clinical challenges.

"HHC's medical library has a vast array of clinical reference needs, and we're proud to be one of the services made available to its many clinicians," said Jay Katzen, President, Clinical Solutions, Elsevier. "Our content is comprehensive, trusted and quick, and this will allow HHC librarians and healthcare professionals to find the most accurate response to help advance their research needs and, ultimately, improve patient care."

For more information about ClinicalKey, visit .

About Elsevier

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs